RIVA-VERAPAMIL SR
LABORATOIRE RIVA INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of RIVA-VERAPAMIL SR in Canada?
Yes. RIVA-VERAPAMIL SR 240MG has an active shortage reported to Health Canada (last updated October 5, 2017).
Why is RIVA-VERAPAMIL SR not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will RIVA-VERAPAMIL SR be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
MYLAN-VERAPAMIL SR
Extended-ReleaseMYLAN PHARMACEUTICALS ULC
Other Products
VERELAN
RECRO GAINESVILLE LLC
NOVO-VERAMIL
TEVA CANADA LIMITED
TARO-VERAPAMIL TAB 120MG
TARO PHARMACEUTICALS INC
ALTI-VERAPAMIL - 120MG
ALTIMED PHARMA INC.
VERAPAMIL TAB 80MG
PRO DOC LIMITEE
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02248082
Strength
240MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Active Ingredient
VERAPAMIL HYDROCHLORIDE
Tier
Unrated
Last Updated
2017-10-05
Reason for Shortage
Disruption of the manufacture of the drug.